2565-005X

2565-005X

S2565-005X2024000400234

10.24875/j.gamo.m23000257

México

México

México

México

México

México

México

México

México

México

México

00 12 2024

00 12 2024

23 4 234 245

1

Real Academia Española

2023

2

2010 73 2 2

141-55

3

2022 33 11 11

1097-118

4

2012 48 18 18

3355-77

5

2010 21 4 4

723-8

6

2015 24 3 3

175-81

7

2017 266 1 1

165-72

8

2015 93 5 5

1096-103

9

2022 42

1-12

10

2007 82 3 3

265-71

11

2008 12 6-7 6-7

565-70

12

European Organisation for Research and Treatment of Cancer Radiation Oncology and Breast Cancer Groups

2015 16

47-56

13

2018 379 2 2

111-21

14

2022 40 16 16

1816-37

15

2021 22 4 4

476-88

16

2021 385 25 25

2336-47

17

2016 34 14 14

1584-93

18

2018 379 2 2

122-37

19

2018 29 suppl_8 suppl_8

20

2017 35 18 18

2062-81

21

2020 31 12 12

1623-49

22

2018 36 19 19

1994-2001

23

2018 36 19 19

1981-90

24

2015 26 12 12

2408-19

25

2016 160 2 2

347-60

26

2018 110 4 4

426-9

27

2021 39 29 29

3293-305

28

2016 14

1

29

2018 124 22 22

4401-7

30

2020 14

1178223420954179

31

2021 59

327-38

32

2022

33

World Health Organization

2015

34

2018 19 6 6

e305-16

35

2018 36 22 22

2326-47

36

2014 32 1 1

19-26

37

2018 14 2 2

85-94

38

2017 35 7 7

766-77

39

2015 13 9 9

1120-30

40

2017 72 3 3

410-6

41

2021 39 6 6

608-18

42

2012 118 13 13

3377-86

43

2018 153 12 12

1090-6

44

2022 29 8 8

4761-2

45

2022 32 2 2

155-8

46

2005 293 9 9

1073-81

47

2014 32 19 19

2010-7

48

2006 1 1

CD004272

49

2018 45 2 2

187-200

50

2019 69

7-34

51

2020 12

1356

52

2017 22 3 3

324-34

53

2015 29 5 5

741-53

54

2011 196 3 3

716-22

55

2017 130 4 4

e210-6

56

ACR-SPR practice parameter for imaging pregnant or potentially pregnant adolescents and women with ionizing radiation

57

2017 35

177-81

58

2012 33 1 1

4-10

59

2017 23 2 2

200-5

60

2014 21 8 8

2506-11

61

2013 22 5 5

657-60

62

2011 54

591601

63

2014 25 10 10

2059-65

64

2012 379

570-9

65

2018 15

6-13

66

2019 11

1669

67

2017 23 4 4

387-94

68

2020 12

3616

69

2015 373 19 19

1824-34

70

2014 16 6 6

500

71

2012 23 12 12

3016-23

72

2011 3 2 2

73-83

73

2010 12

186-92

74

2015 41 4 4

301-9

75

2013 137 2 2

349-57

76

2007 110

507-10

77

Genentech, Inc

78

2019 30

1601-12

79

2013 22

980-5

80

2010 12

186-92

81

ACTORDS Study Group

2007 357

1179-89

82

2015 125

197-203

83

2018 378

2311-20

84

2023 73 1 1

17-48

85

2022 38

1849-63

86

2019 173 1 1

37-48

87

2018 29

405-17

88

2017 44 4 4

267-72

89

2005 10

471-9

90

2002 4 1 1

R2

91

1997 60

313-9

92

2003 63

342-7

93

2017 82

219-27

94

2015 20

1-7

95

2008 3 3 3

183-9

96

1999 85 3 3

629-39

97

2011 91 2 2

319-23

98

2014 86 2 2

74-7

99

2013 717 13 13

71-83

100

2005 104

2359-64

101

2010 116

3558-68

102

2020 123 1 1

33-7

103

2019 120

301-5

104

2013 381

805-16

105

2018 25 6 6

1530

106

2015 8

53

107

2013 108

22592263

108

2015 149

269-75

109

2020 15;26 6 6

1208-12

110

2022 193 1 1

95-103

111

2018 379 8 8

753-63

112

2017 377

523-33

113

2020 21 12 12

1493-504

114

2022 387

217-26